Venrock Adviser, LLC: holdings and changes
Number 2 of the top 100 funds by copy return. Venrock Adviser, LLC reported 34 US stocks worth $2.1B for the quarter ending 2026-09-30 and changed 7 new, 6 added, 5 trimmed and 6 sold since 2026-06-30.
Copy return, 4 quarters+131.9%
US 500, same time+14.5%
Size$2.1B
Stocks34
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| ORKA Oruka Therapeutics INC | 16.79% | $346M | 4,148,428 | |
| ERAS Erasca INC Com | ADD +12% | 14.31% | $294M | 20,089,932 |
| AEGLEA BIOTHER Aeglea Biotherapeutics INC | TRIM -17% | 10.75% | $221M | 2,485,448 |
| KRSA Korsana Biosciences INC | BUY | 7.07% | $146M | 4,549,585 |
| SVRA Savara INC | ADD +33% | 4.91% | $101M | 19,568,534 |
| OCUL Ocular Therapeutix INC | 3.86% | $79M | 10,346,926 | |
| DMRA Damora Therapeutics INC Com Shs | BUY | 3.73% | $77M | 3,603,595 |
| DNTH Dianthus Therapeutics INC | TRIM -30% | 3.52% | $72M | 822,020 |
| VRDN Viridian Therapeutics INC | 3.26% | $67M | 3,257,917 | |
| VOR Vor Biopharma INC | 2.82% | $58M | 3,041,719 | |
| COGT Cogent Biosciences INC | 2.55% | $53M | 1,642,166 | |
| ANL Adlai Nortye LTD | 2.50% | $51M | 3,212,731 | |
| JBIO Jade Biosciences INC | 2.20% | $45M | 3,220,364 | |
| QUIT Achieve Life Sciences INC | ADD +100% | 2.16% | $44M | 5,502,064 |
| MAZE Maze Therapeutics | TRIM -4% | 2.04% | $42M | 1,545,616 |
| ORIC Oric Pharmaceuticals INC | TRIM -32% | 1.93% | $40M | 2,944,056 |
| DYN Dyne Therapeutics INC | 1.70% | $35M | 2,173,913 | |
| ADRX Adarx Pharmaceuticals INC | BUY | 1.58% | $32M | 1,625,793 |
| CBIO Crescent Biopharma INC. | 1.51% | $31M | 2,133,734 | |
| RLMD Relmada Therapeutics INC | ADD +9% | 1.36% | $28M | 7,445,050 |
| ZURA Zura Bio LTD | 1.30% | $27M | 6,434,990 | |
| XFOR X4 Pharmaceuticals INC Com New | ADD +295% | 1.08% | $22M | 7,644,072 |
| CULLINAN ONCOL Cullinan Oncology INC | 1.03% | $21M | 1,379,965 | |
| SRZN Surrozen INC | 0.99% | $20M | 632,931 | |
| PBLS Parabilis Medicines, INC. | 0.98% | $20M | 625,000 | |
| ARVN Arvinas INC | BUY | 0.73% | $15M | 1,952,533 |
| IPSC Century Therapeutics INC | 0.72% | $15M | 8,695,652 | |
| ENTX Entera Bio LTD | BUY | 0.72% | $15M | 5,106,337 |
| ARTV Artiva Biotherapeutics INC | 0.71% | $15M | 2,043,596 | |
| ANRO Alto Neuroscience INC | 0.62% | $13M | 500,000 | |
| KRRO Korro Bio INC | TRIM -56% | 0.21% | $4M | 443,431 |
| TCGX Tcgx Acquisition Corp | BUY | 0.18% | $4M | 300,000 |
| RACD Research Alliance Corp Iv | BUY | 0.17% | $4M | 300,000 |
| MTRI Inmed Pharmaceuticals INC | ADD +308% | 0.01% | $200k | 133,378 |
| APOGEE THERA I Apogee Thera INC | SELL | 0% | was $1.1B | 0 |
| GALECTO INC Galecto INC | SELL | 0% | was $94M | 0 |
| ELVN Enliven Therapeutics INC | SELL | 0% | was $27M | 0 |
| CYBIN INC Cybin INC | SELL | 0% | was $26M | 0 |
| CTMX Cytomx Therapeutics INC | SELL | 0% | was $19M | 0 |
| RACC Research Alliance Corp III | SELL | 0% | was $3M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-06-30 → 2023-09-30 | -20.7% | -3.6% |
| 2023-09-30 → 2023-12-31 | +21.4% | +11.2% |
| 2023-12-31 → 2024-03-31 | +54.4% | +10.0% |
| 2024-06-30 → 2024-09-30 | +20.7% | +5.4% |
| 2024-09-30 → 2024-12-31 | -19.7% | +2.1% |
| 2024-12-31 → 2025-03-31 | -24.9% | -4.6% |
| 2025-03-31 → 2025-06-30 | +13.5% | +10.5% |
| 2025-06-30 → 2025-09-30 | +32.7% | +7.8% |
| 2025-09-30 → 2025-12-31 | +51.7% | +2.4% |
| 2025-12-31 → 2026-03-31 | +24.3% | -4.6% |
| 2026-03-31 → 2026-06-30 | +33.0% | +14.8% |
| 2026-06-30 → 2026-09-30 | -7.5% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Fairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP